Travere Therapeutics Inc (NASDAQ: TVTX) stock enjoyed a major increase of 10.5% on 7/8/24. The shares closed at $8.72. Moreover, this advance was accompanied by above average trading volume at 123% of normal. Relative to the market the stock has been weak over the last nine months but has risen 5.3% during the last week.
Current PriceTarget Research Rating
TVTX’s future returns on capital are forecasted to be in line with the cost of capital. Accordingly, the company is expected to continue to be Value Creation neutral.
Travere Therapeutics has a current Value Trend Rating of F (Lowest Rating). This rating combines consistent signals from two proprietary PTR measures of a stock’s attractiveness. Travere Therapeutics has a poor Power Rating of 21 and a very low Appreciation Score of 8, with the Lowest Value Trend Rating the result.
Rating Review
In light of this very positive price change we are reviewing our current Overall Rating of F. This review will be completed in the next several days.
Be the first to comment